SCHEMBL7769224

SCHEMBL7769224

COc1ccccc1N1CCN(C(N)Cc2nc3ccccc3s2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.49
MAPT P10636 3/20 0.49
NPC1 O15118 2/20 0.49
PKM P14618 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NLRP1 Q9C000 1/20 0.48
DRD2 P14416 4/20 0.48
DRD3 P35462 3/20 0.48
DRD4 P21917 2/20 0.48
ALDH1A1 P00352 2/20 0.47
TSHR P16473 1/20 0.47
PPARG P37231 1/20 0.47
NCOA2 Q15596 1/20 0.47
NCOA1 Q15788 1/20 0.47
NCOA3 Q9Y6Q9 1/20 0.47
POLB P06746 2/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
HTR1A P08908 1/20 0.44
HTR7 P34969 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL7773337 0.92 MAPT (0.48) RAB9AMAPTNPC1PKMSMN1; SMN2
SCHEMBL7776876 0.91 MAPT (0.50) RAB9AMAPTNPC1PKMSMN1; SMN2
Bromide SCHEMBL7775407 0.90 MAPT (0.49) RAB9AMAPTNPC1PKMSMN1; SMN2
SCHEMBL7769232 0.89 ALDH1A1 (0.51) RAB9AMAPTSMN1; SMN2DRD2DRD3
SCHEMBL7856190 0.89 POLB (0.45) RAB9AMAPTNPC1DRD2DRD3
Bromide SCHEMBL7773371 0.89 ALDH1A1 (0.50) RAB9AMAPTSMN1; SMN2DRD2DRD3
SCHEMBL7773363 0.87 HTR7 (0.46) RAB9ASMN1; SMN2DRD3ALDH1A1TSHR
SCHEMBL7769235 0.86 HTR7 (0.44) RAB9AMAPTNPC1SMN1; SMN2DRD2
Bromide SCHEMBL7773418 0.86 HTR7 (0.45) RAB9ASMN1; SMN2DRD3ALDH1A1TSHR
SCHEMBL7776882 0.85 DRD2 (0.47) RAB9AMAPTNPC1SMN1; SMN2NLRP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1325397-A 2-piperazino alkylatnino benzoazole derivatives: dopamine receptor subtype sepcific ligands NEUROGEN CORP (US) 2001-12-05 CN claimed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP claimed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO claimed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO claimed
EP-1117663-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2001-07-25 EP disclosed
WO-2000018767-A9 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORP (US) 2001-04-19 WO disclosed
WO-2000018767-A2 2-PIPERAZINO ALKYLAMINO BENZOAZOLE DERIVATIVES: DOPAMINE RECEPTOR SUBTYPE SPECIFIC LIGANDS NEUROGEN CORPORATION (US) 2000-04-06 WO disclosed